Therapeutic interventions demonstrated enhanced ISI concomitant with reduced HOMA-IR values relative to model controls, indicating that GSP significantly improved insulin resistance and promoted insulin utilization in T2D rats. The gene discussed is INS; the disease is type 2 diabetes mellitus.